延长澳大利亚激素长效可逆避孕器具的使用期限:探索COVID-19指导前后一组用户的使用模式

IF 1.8 4区 医学 Q3 INFECTIOUS DISEASES
Sexual health Pub Date : 2025-06-01 DOI:10.1071/SH25004
Tahlee B Stevenson, Alice R Rumbold, Kelly Hall, Jenni Ilomaki, Deborah Bateson, Danielle Mazza, Luke E Grzeskowiak
{"title":"延长澳大利亚激素长效可逆避孕器具的使用期限:探索COVID-19指导前后一组用户的使用模式","authors":"Tahlee B Stevenson, Alice R Rumbold, Kelly Hall, Jenni Ilomaki, Deborah Bateson, Danielle Mazza, Luke E Grzeskowiak","doi":"10.1071/SH25004","DOIUrl":null,"url":null,"abstract":"<p><p>Background As the accessibility of health services fluctuated throughout the COVID-19 pandemic, recommendations supporting off-label extended use of hormonal long-acting reversible contraceptive (LARC) devices began to appear around the globe. Supported by emerging evidence, these recommendations were intended to encourage consumers to postpone device replacement and reduce the need for face-to-face care interactions. Methods In this population-based cohort study, data from the nationally representative Australian Pharmaceutical Benefits Scheme 10% sample were analysed. Specifically, logistic regression analysis was undertaken for females aged 15-49years who had a hormonal LARC dispensed to them within the COVID-19 pandemic period (between February 2017 and November 2021) to assess timing of replacement, compared with timing for pre-COVID counterparts. Results Extended use periods were observed in less than 10% of hormonal implant or intrauterine device users in both the pre- and post-COVID cohorts, with 40% replacing their device on time, and around 50% with no record of replacement. No statistically significant changes occurred after the onset of COVID-19. Conclusions Despite recommendations for extending LARC device use periods, typical usage patterns were maintained in Australia throughout the COVID-19 pandemic. Given these extended use periods have since been made permanent in Australian clinical guidelines, targeted education for consumers and providers is likely to be required to ensure understanding, uptake and consistent implementation.</p>","PeriodicalId":22165,"journal":{"name":"Sexual health","volume":"22 ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Extending the use period of hormonal long-acting reversible contraceptive devices in Australia: exploring patterns of use in a cohort of users before and after COVID-19 guidance.\",\"authors\":\"Tahlee B Stevenson, Alice R Rumbold, Kelly Hall, Jenni Ilomaki, Deborah Bateson, Danielle Mazza, Luke E Grzeskowiak\",\"doi\":\"10.1071/SH25004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Background As the accessibility of health services fluctuated throughout the COVID-19 pandemic, recommendations supporting off-label extended use of hormonal long-acting reversible contraceptive (LARC) devices began to appear around the globe. Supported by emerging evidence, these recommendations were intended to encourage consumers to postpone device replacement and reduce the need for face-to-face care interactions. Methods In this population-based cohort study, data from the nationally representative Australian Pharmaceutical Benefits Scheme 10% sample were analysed. Specifically, logistic regression analysis was undertaken for females aged 15-49years who had a hormonal LARC dispensed to them within the COVID-19 pandemic period (between February 2017 and November 2021) to assess timing of replacement, compared with timing for pre-COVID counterparts. Results Extended use periods were observed in less than 10% of hormonal implant or intrauterine device users in both the pre- and post-COVID cohorts, with 40% replacing their device on time, and around 50% with no record of replacement. No statistically significant changes occurred after the onset of COVID-19. Conclusions Despite recommendations for extending LARC device use periods, typical usage patterns were maintained in Australia throughout the COVID-19 pandemic. Given these extended use periods have since been made permanent in Australian clinical guidelines, targeted education for consumers and providers is likely to be required to ensure understanding, uptake and consistent implementation.</p>\",\"PeriodicalId\":22165,\"journal\":{\"name\":\"Sexual health\",\"volume\":\"22 \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sexual health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1071/SH25004\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexual health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1071/SH25004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景:在2019冠状病毒病大流行期间,卫生服务可及性出现波动,全球开始出现支持在说明书外延长使用激素长效可逆避孕装置的建议。在新证据的支持下,这些建议旨在鼓励消费者推迟设备更换,减少面对面护理互动的需要。方法在这项基于人群的队列研究中,分析了来自全国代表性的澳大利亚药品福利计划10%样本的数据。具体而言,对在COVID-19大流行期间(2017年2月至2021年11月)接受激素LARC的15-49岁女性进行了逻辑回归分析,以评估替代时间,与COVID-19前的时间进行比较。结果在covid前后的队列中,不到10%的激素植入物或宫内节育器使用者延长了使用时间,其中40%的人按时更换了设备,约50%的人没有更换记录。COVID-19发病后无统计学意义的变化。尽管建议延长LARC设备的使用期限,但在2019冠状病毒病大流行期间,澳大利亚保持了典型的使用模式。鉴于这些延长的使用期限已经在澳大利亚临床指南中成为永久性的,可能需要对消费者和提供者进行有针对性的教育,以确保理解、吸收和一致的实施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Extending the use period of hormonal long-acting reversible contraceptive devices in Australia: exploring patterns of use in a cohort of users before and after COVID-19 guidance.

Background As the accessibility of health services fluctuated throughout the COVID-19 pandemic, recommendations supporting off-label extended use of hormonal long-acting reversible contraceptive (LARC) devices began to appear around the globe. Supported by emerging evidence, these recommendations were intended to encourage consumers to postpone device replacement and reduce the need for face-to-face care interactions. Methods In this population-based cohort study, data from the nationally representative Australian Pharmaceutical Benefits Scheme 10% sample were analysed. Specifically, logistic regression analysis was undertaken for females aged 15-49years who had a hormonal LARC dispensed to them within the COVID-19 pandemic period (between February 2017 and November 2021) to assess timing of replacement, compared with timing for pre-COVID counterparts. Results Extended use periods were observed in less than 10% of hormonal implant or intrauterine device users in both the pre- and post-COVID cohorts, with 40% replacing their device on time, and around 50% with no record of replacement. No statistically significant changes occurred after the onset of COVID-19. Conclusions Despite recommendations for extending LARC device use periods, typical usage patterns were maintained in Australia throughout the COVID-19 pandemic. Given these extended use periods have since been made permanent in Australian clinical guidelines, targeted education for consumers and providers is likely to be required to ensure understanding, uptake and consistent implementation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Sexual health
Sexual health 医学-传染病学
CiteScore
2.30
自引率
12.50%
发文量
121
审稿时长
6-12 weeks
期刊介绍: Sexual Health publishes original and significant contributions to the fields of sexual health including HIV/AIDS, Sexually transmissible infections, issues of sexuality and relevant areas of reproductive health. This journal is directed towards those working in sexual health as clinicians, public health practitioners, researchers in behavioural, clinical, laboratory, public health or social, sciences. The journal publishes peer reviewed original research, editorials, review articles, topical debates, case reports and critical correspondence. Officially sponsored by: The Australasian Chapter of Sexual Health Medicine of RACP Sexual Health Society of Queensland Sexual Health is the official journal of the International Union against Sexually Transmitted Infections (IUSTI), Asia-Pacific, and the Asia-Oceania Federation of Sexology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信